Gilead Sciences Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $37.26B | $57.70B | $10.29B |
| Jun 2017 | $37.59B | $60.26B | $8.71B |
| Sep 2017 | $39.82B | $64.66B | $11.51B |
| Dec 2017 | $49.84B | $70.28B | $7.59B |
| Mar 2018 | $44.79B | $65.38B | $7.64B |
| Jun 2018 | $43.68B | $65.36B | $13.23B |
| Sep 2018 | $41.44B | $64.31B | $14.57B |
| Dec 2018 | $42.29B | $63.68B | $17.94B |
| Mar 2019 | $40.89B | $62.84B | $16.93B |
| Jun 2019 | $40.59B | $63.21B | $11.24B |
| Sep 2019 | $38.54B | $59.15B | $9.47B |
| Dec 2019 | $39.10B | $61.63B | $11.63B |
| Mar 2020 | $37.67B | $59.74B | $10.05B |
| Jun 2020 | $37.91B | $55.93B | $6.75B |
| Sep 2020 | $43.43B | $60.88B | $12.89B |
| Dec 2020 | $50.21B | $68.41B | $6.00B |
| Mar 2021 | $48.54B | $67.49B | $4.07B |
| Jun 2021 | $48.28B | $67.98B | $4.89B |
| Sep 2021 | $45.63B | $67.10B | $4.36B |
| Dec 2021 | $46.88B | $67.95B | $5.34B |
| Mar 2022 | $43.15B | $63.08B | $4.30B |
| Jun 2022 | $42.63B | $62.87B | $4.74B |
| Sep 2022 | $41.48B | $62.56B | $4.70B |
| Dec 2022 | $41.93B | $63.17B | $5.41B |
| Mar 2023 | $40.88B | $61.88B | $4.94B |
| Jun 2023 | $41.18B | $62.34B | $5.70B |
| Sep 2023 | $40.06B | $62.37B | $5.71B |
| Dec 2023 | $39.29B | $62.13B | $6.09B |
| Mar 2024 | $38.75B | $56.29B | $4.72B |
| Jun 2024 | $35.30B | $53.58B | $2.77B |
| Sep 2024 | $36.05B | $54.53B | $5.04B |
| Dec 2024 | $39.67B | $59.00B | $9.99B |
| Mar 2025 | $37.27B | $56.43B | $7.93B |
| Jun 2025 | $36.05B | $55.72B | $5.14B |
| Sep 2025 | $36.99B | $58.53B | $7.33B |
| Dec 2025 | $36.32B | $59.02B | $7.56B |
| Mar 2026 | $32.76B | $56.28B | $7.63B |
| Jun 2026 | $37.53B | $49.36B | $3.18B |